ABUS Arbutus Biopharma Corporation

NASDAQ
$3.88

Arbutus Biopharma Corporation (ABUS) is expected to report earnings on February 9, 2027, before the market open.

Arbutus Biopharma Reported Earnings
Tuesday, November 10, 2026 · 7:30 AM ET
Earnings Date
Feb 9
Tuesday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.